Normal allele: CC
Associated with lower plasma dopamine beta-hydroxylase activity, increased risk of Parkinson's disease, ADHD.
Polymorphism rs1611115 is related to topics like this:
Research and publications:
14991826 Functional polymorphisms regulating dopamine beta-hydroxylase influence Parkinson's disease.
15505174 The -1021C->T DBH gene variant is not associated with epilepsy or antiepileptic drug response.
17503507 DBH-1021C--u003eT does not affect the risk or age of onset of Parkinson's disease.
18330705 Physiogenomic analysis of localized FMRI brain activity in schizophrenia.
18722802 Association of dopamine beta-hydroxylase -1021Cu003eT and Parkinson's disease.
19540311 Genetics of anxiety and trauma-related disorders.
20418890 Genome-wide meta-analyses identify multiple loci associated with smoking behavior
20691427 Genetic associations of brain structural networks in schizophrenia: a preliminary study
21216270 Role of gene-gene/gene-environment interaction in the etiology of eastern Indian ADHD probands.
21368917 Epistasis between neurochemical gene polymorphisms and risk for ADHD.
21808609 Components of cross-frequency modulation in health and disease.
22105624 The genetics of attention deficit/hyperactivity disorder in adults, a review.
22224195 Epigenetics in Developmental Disorder: ADHD and Endophenotypes.
22640745 The COMT Val158 allele is associated with impaired delayed-match-to-sample performance in ADHD.
22906516 Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase.
23384717 Association between 1603C>T polymorphism of DBH gene and bipolar disorder in a Turkish population.
23416088 Genotype-independent reduction of plasma dopamine beta-hydroxylase activity in Alzheimer's disease.
23458673 DBH gene as predictor of response in a cocaine vaccine clinical trial.
23808549 Candidate gene associations with withdrawn behavior.
23849431 Pharmacogenetic randomized trial for cocaine abuse: disulfiram and α1A-adrenoceptor gene variation.
24667010 Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome.
24724887 Pharmacogenetics of naltrexone and disulfiram in alcohol dependent, dually diagnosed veterans.
25045619 The Genetics, Neurogenetics and Pharmacogenetics of Addiction.
25326128 Regulatory polymorphisms in human DBH affect peripheral gene expression and sympathetic activity.
25819021 A review of pharmacogenetic studies of substance-related disorders.
26272535 The placebo effect: From concepts to genes.
26868704 Analysis of dopamine beta hydroxylase gene polymorphisms in migraine.
29498170 Pharmacogenetics of Dopamine β-Hydroxylase in cocaine dependence therapy with doxazosin.
30187307 Association of the DBH gene rs1611115 polymorphism with Parkinson's disease: a meta-analysis.
31552390 Placebo effects and the molecular biological components involved.
34453125 Molecular genetics of cocaine use disorders in humans.
34638656 Towards Understanding the Genetic Nature of Vasovagal Syncope.